Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.00 (0.00%)
Bid:
24.00
Ask:
26.00
Spread: 2.00 (8.333%)
Market Cap: £27.00m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Derivative Claim - Update

16 Jul 2015 16:09

RNS Number : 2980T
Elektron Technology PLC
16 July 2015
Β 

Elektron Technology plc

("Elektron" or the "Company")

Β 

Derivative Claim - Update

Β 

As announced on 18 June 2015, subject to rights of appeal, Mr Barrie Bridge's application for permission to continue a derivative claim against current directors, Keith Daley and John Wilson, and former directors, Noah Franklin and Simon Acland, was refused by His Honour Judge Hodge QC sitting in the Liverpool District Registry of the High Court on 16 and 17 June 2015.

Β 

The Company has now received notice of Mr Bridge's application to the Court of Appeal for permission to appeal the order of His Honour Judge Hodge QC. Mr Bridge has stated that since his counsel did not appear at the hearing, his counsel has advised him that his grounds for appeal are "by nature somewhat speculative". Therefore Mr Bridge has asked for a period of 28 days from receipt of a transcript of the judgment for the service of perfected grounds and a supporting document.

Β 

The Company anticipates that the Court of Appeal will not require a hearing and that the outcome of its decision will be known later this Summer.

Β 

Further updates will be provided in due course as appropriate.

Β 

A transcript of the above-mentioned judgment of His Honour Judge Hodge QC has been requested by the Company and will be posted on the Company's website www.elektron-technology.com when it is available.

Β 

Β 

For further information:

Β 

Elektron Technology www.elektron-technology.com

+44 (0) 1223 371 000

Andy Weatherstone - Chief Financial Officer

Martin Reeves - Company Secretary

finnCap (Nominated Adviser, Financial Adviser and Broker)

+44 (0)20 7220 0500

Ed Frisby/Scott Mathieson (Corporate Finance)

Malar Velaigam (Corporate Broking)

Β 

Β 

Notes to Editors

Β 

Elektron conceives designs and markets innovative engineered products and services for businesses at its technology hub in Cambridge. It has a multi skilled team of engineers and product line specialists focused on the opportunities created by disruptive global trends in the following areas:

Β 

Β· Demand for ubiquitous power and data: Connectivity Solutions

Β· Internet of Things, cloud computing and mobile devices: enabling automation and management of a new wave of business processes: Checkit

Β· Growth in high precision manufacture: Nano-positioning

Β· Healthcare for the ageing population: Ophthalmology

Β· Connected customer experiences and service delivery: E-Commerce and E-Service

Β 

In addition, Elektron owns a portfolio of well-established products and brands which provide customer access and feedback.

Β 

Elektron Technology is headquartered in Cambridge and its shares are admitted to trading on the AIM market of the London Stock Exchange.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCLLFIEDAIRLIE
Date   Source Headline
10th Aug 20237:00 amRNSTrading update notice of results & contract
8th Jun 20234:08 pmRNSResult of AGM
24th May 20233:29 pmRNSDirector/PDMR Shareholding
15th May 20231:04 pmRNSPosting of Annual Report and Notice of AGM
24th Apr 20237:00 amRNSPreliminary Results
13th Apr 20231:36 pmRNSNotice of Results and Investor Presentation
23rd Mar 20235:25 pmRNSDirector/PDMR Shareholding
13th Mar 20238:55 amRNSStatement re. Silicon Valley Bank
16th Feb 20237:00 amRNSTrading Update and Notice of Results
26th Jan 20234:10 pmRNSDirectorate Change
23rd Jan 20237:00 amRNSDirector/PCA Dealing
10th Jan 20237:00 amRNSAppointment of Non-Executive Director
10th Jan 20237:00 amRNSGrant of options and PDMR dealings
5th Jan 20237:00 amRNSContract wins and investor presentation
12th Dec 20225:14 pmRNSDirector/PDMR Shareholding
27th Sep 202212:28 pmRNSHolding(s) in Company
23rd Sep 20226:16 pmRNSDirector/PDMR Shareholding
16th Sep 20225:36 pmRNSDirector Dealing
15th Sep 20227:00 amRNSInterim Results
6th Sep 20227:00 amRNSInvestor Presentation
22nd Aug 20221:07 pmRNSDirector/PDMR Shareholding
11th Aug 20227:00 amRNSTrading Update and Notice of Interim Results
9th Jun 20223:09 pmRNSResult of AGM
13th May 20225:17 pmRNSPosting of Annual Report and Notice of AGM
13th May 20227:00 amRNSInvestor Conference
4th May 20227:00 amRNSContract Renewal
28th Apr 20227:00 amRNSPreliminary Results
29th Mar 20227:00 amRNSGrant of options and PDMR dealings
23rd Feb 20227:00 amRNSPDMR Dealing
22nd Feb 20227:00 amRNSPDMR Dealing
17th Feb 20227:00 amRNSTrading update
1st Feb 20227:00 amRNSContract win
22nd Dec 20212:06 pmRNSHolding(s) in Company
20th Dec 20217:01 amEQSCheckit (CKT): SaaS software for the deskless workforce
17th Dec 20212:44 pmRNSDirector/PDMR Shareholding
16th Dec 202111:52 amRNSResult of General Meeting and Admission
2nd Dec 202111:00 amRNSHolding(s) in Company
2nd Dec 202111:00 amRNSHolding(s) in Company
29th Nov 202111:44 amRNSPosting of Circular and Notice of General Meeting
26th Nov 20212:23 pmRNSResult of Placing
26th Nov 20217:00 amRNSProposed Placing
28th Oct 20217:00 amRNSContract win
16th Sep 20217:00 amRNSInterim Results
12th Aug 20217:00 amRNSTrading Update and Notice of Interim Results
6th Aug 20213:13 pmRNSDirector/PDMR Shareholding
15th Jul 20217:00 amRNSProduct Update
13th Jul 20215:08 pmRNSGrant of options and PDMR dealings
12th Jul 20217:00 amRNSAppointment of Chief Executive Officer
29th Jun 20214:01 pmRNSCapital Markets Day
10th Jun 20219:16 amRNSPDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.